What type of study is this?

Microbiological evidence for the trisubstituted benzimidazoles targeting MmpL3 in Mycobacterium tuberculosis

View Full Paper

Ask AI

Bookmark

Authors

Observational analysis shows that benzimidazoles reduce bacterial counts in Mycobacterium tuberculosis, indicating MmpL3 targeting.

Trisubstituted benzimidazoles significantly reduced bacterial counts in an acute mouse infection model, demonstrating potent antitubercular activity.
MICs were favorable, while cell wall-damaging phenotypes were observed in SBZ-treated Mycobacterium tuberculosis, resembling effects of other cell wall inhibitors.
Bacterial cytological profiling revealed that SBZs primarily target MmpL3, with strains having mmpL3 mutations showing resistance to these compounds.
The study proposes a molecular docking model based on MmpL3's crystal structure to enhance the understanding of the inhibition mechanism.

Zhang et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark